Name of the product: PLUSPLATIN 50

Active ingredient: Oxaliplatin 50 mg

Dosage form: lyophilised injection

Name of the product: PLUSPLATIN 100

Active ingredient: Oxaliplatin 100 mg

Dosage form: lyophilised injection

Dispensing requirements: Rx only

Argentine Industry

Composition:

PLUSPLATIN 50:

Each glass bottle contains oxaliplatin 50 mg and lactose monohydrate.

PLUSPLATIN 100:

Each glass bottle contains oxaliplatin 100 mg and lactose monohydrate.

Indications:

PLUSPLATIN is indicated for the treatment of the colonrectal metastasic cancer after the therapy with fluoropirimides in single or associated chemotherapies.

Therapeutic action:

Antineoplastic.

Storage:

Keep at temperature below 25º C, in the marketed packing.

Marketed presentations:

PLUSPLATIN 50:

Packs containing 1 glass bottle.

PLUSPLATIN 50:

Packs containing 1 glass bottle.

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 46950

Laboratorio DOSA S.A.

Girardot 1369, (C1427AKC) Buenos Aires, Argentine

Pharmaceutical Director: María C. Terzo, Pharmacist